Patents/Assignees

GENEUIN-TECH CO., Ltd.

1 patent in portfolio

US11603409utility2023
Humanized DR4 Antibody Gene Having Apoptosis-inducing Activity and Dual-acting Chimeric Antigen Receptor T Cell or Natural Killer Cell Therapeutic Agent Using Same
0 cites